PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23239606-4	2013	beta-TCP grafting also induced higher plasmatic levels of RANK-L, compared to beta-TCMP and control (blood clot) groups at 21st day (p < 0.05).	beta-tricalcium phosphate	0-8	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	58-64	
25998451-8	2015	Hydroxyapatite, beta-tricalcium phosphate and CPPD treatments significantly enhanced RANKL/M-CSF-induced mRNA expression of TRAP, cathepsin K and CTR.	beta-tricalcium phosphate	16-41	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	85-90	
25245204-0	2014	Incorporation of RANKL promotes osteoclast formation and osteoclast activity on beta-TCP ceramics.	beta-tricalcium phosphate	80-88	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	17-22	
25245204-4	2014	RANKL was adsorbed superficially onto beta-TCP ceramics or incorporated into a crystalline layer of calcium phosphate by the use of a co-precipitation technique.	beta-tricalcium phosphate	38-46	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	0-5	
25245204-10	2014	When co-precipitated onto beta-TCP ceramics RANKL supported the formation of mature osteoclasts.	beta-tricalcium phosphate	26-34	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	44-49	
25245204-13	2014	Our in vitro study shows that RANKL incorporated into beta-TCP ceramics induces the formation of active, resorbing osteoclasts on the material surface.	beta-tricalcium phosphate	54-62	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	30-35	
23239606-6	2013	RANK-L/OPG ratio increased on beta-TCP group and attained a peak on the 21st day.	beta-tricalcium phosphate	30-38	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	0-6